For more VICC news, visit their website »
Sam Chang, MD, MBA, has been named chief surgical officer at Vanderbilt-Ingram Cancer Center (VICC), a new leadership position responsible for advancing excellence in surgical care in cancer patients, expanding service locations, maximizing resource efficiencies and maintaining high-quality standards among other duties.
Combining two drugs reduced colorectal cancer cell growth in vitro and in an animal model, suggesting the combination may be a promising treatment for patients.
Researchers from Vanderbilt University Medical Center recently completed a study to create a standardized protocol for using acupressure to treat newborns with opioid withdrawal syndrome.
Patients with ALK-positive non-small cell lung cancer treated with ensartinib fared better and lived longer than those who received crizotinib, according to results of a phase 3 study.
A computational technique that combines the effect of multiple genomic variants has the potential to identify high-risk individuals for cancer prevention.
The first study of appendiceal cancer patterns and survival by race/ethnicity among patients younger than 50 in the U.S. showed survival disparities.